Found: 7
Select item for more details and to access through your institution.
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 4, p. 492, doi. 10.1007/s11547-023-01615-8
- By:
- Publication type:
- Article
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients—A Single Centre Experience.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 649, doi. 10.3390/cancers16030649
- By:
- Publication type:
- Article
Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) in older patients with high‐risk aggressive diffuse large B‐cell lymphoma: A real‐life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 725, doi. 10.1111/ejh.13957
- By:
- Publication type:
- Article
Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 115, doi. 10.1159/000334705
- By:
- Publication type:
- Article
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 3, p. 430, doi. 10.3390/medicina60030430
- By:
- Publication type:
- Article